Situated at 16633 Ventura Boulevard in Encino, the California Center for Reproductive Health occupies a central position in the San Fernando Valley's fertility care landscape. The practice serves patients from across the greater Los Angeles area — including the Valley communities of Tarzana, Sherman Oaks, Woodland Hills, and Calabasas, as well as patients traveling from the Westside, South Bay, and beyond. With three locations (Encino, West Hollywood, and Valencia), the clinic has built a regional footprint that allows it to reach a geographically diverse patient base while maintaining continuity of care under a single clinical team. The clinic holds a 4.5-star rating across more than 267 patient reviews, reflecting a consistently positive patient experience across what is a deeply demanding subspecialty of medicine.
Physicians and Clinical Team
The California Center for Reproductive Health is led by Dr. Eliran Mor, MD, a board-certified Reproductive Endocrinologist and Infertility specialist who serves as Medical Director across all three clinic locations. Dr. Mor's training spans three countries and some of the country's most rigorous academic programs.
He earned his medical degree from Tel Aviv University–Sackler School of Medicine in Israel, then completed a four-year residency in Obstetrics and Gynecology at New York Methodist Hospital in Brooklyn, New York. He subsequently undertook a three-year fellowship in Reproductive Endocrinology and Infertility at the University of Southern California — one of the strongest REI training programs in the western United States. Dr. Mor is board-certified in both Reproductive Endocrinology and Infertility and Obstetrics and Gynecology, a dual certification that reflects comprehensive training across the full spectrum of women's reproductive medicine.
Over the course of his career, Dr. Mor has pursued research across a wide range of reproductive topics, including polycystic ovary syndrome (PCOS), ovarian stimulation protocols for IVF, male factor infertility, insulin resistance and its relationship to fertility, tubal factor infertility, congenital uterine anomalies, emergency contraception, neuroendocrinology, and pregnancy at advanced reproductive age. He is affiliated with Encino Hospital Medical Center and brings both clinical depth and a research orientation to his patient care. With nearly three decades of experience in reproductive medicine, Dr. Mor is recognized among the leading reproductive endocrinologists in the San Fernando Valley and greater Los Angeles region.
The clinical support team at CCRH includes dedicated nursing staff and embryology personnel across the three sites, providing continuity from initial consultation through treatment and beyond.
Services and Treatments
The California Center for Reproductive Health offers a comprehensive menu of fertility services, covering the full range of diagnoses and treatment approaches encountered in a busy reproductive endocrinology practice:
- IVF (In Vitro Fertilization) and embryo transfer, including conventional stimulation cycles and freeze-all protocols
- Access IVF, a lower-cost, minimal-stimulation IVF option for appropriate candidates
- Intrauterine Insemination (IUI) and artificial insemination
- Intracytoplasmic Sperm Injection (ICSI) for male factor infertility
- Egg freezing (oocyte cryopreservation) for fertility preservation
- Embryo freezing and frozen embryo transfer (FET)
- Egg donation — both as a recipient and as a donor program
- Gestational surrogacy coordination and medical management
- Gender selection (preimplantation genetic testing for sex selection)
- Preimplantation Genetic Testing (PGT) for chromosomal abnormalities and single-gene disorders
- Tubal reversal surgery, including reversible tubal ligation procedures
- LGBTQ+ fertility services, including reciprocal IVF, known donor insemination, and family-building support for same-sex couples and transgender individuals
- Diagnosis and treatment of infertility conditions, including endometriosis, PCOS, diminished ovarian reserve (DOR), ovarian failure, tubal factor, cervical factor, uterine factor, male factor infertility, and recurrent pregnancy loss
The breadth of services — particularly the combination of surgical tubal reversal expertise alongside a full IVF program, and the dedicated LGBTQ+ care pathway — distinguishes CCRH from smaller single-service practices in the Valley.
Laboratory and Success Rates
CCRH operates its own embryology laboratory, which supports IVF stimulation monitoring, egg retrieval, fertilization, embryo culture, cryopreservation, and frozen embryo transfer procedures across the Encino flagship and its satellite locations. The lab employs vitrification for egg and embryo cryopreservation — the current gold standard for freeze-survival rates — and provides PGT biopsy support for chromosomal and genetic screening prior to transfer.
The clinic publishes success rate data through SART (the Society for Assisted Reproductive Technology) and emphasizes that its outcomes consistently exceed national averages. Specific cycle-level data — including clinical pregnancy rates and live birth rates broken down by patient age and treatment type — is available through the clinic's SART profile. As with all fertility clinics, patients should review this data in context: success rates are meaningfully influenced by the age distribution and diagnostic mix of the patient population being treated, not just by laboratory or clinical quality.
For independent, government-verified outcome data, the CDC ART Surveillance Reports provide annual clinic-level data for all reporting fertility programs nationwide, and represent the most standardized basis for cross-clinic comparison.
Patient Experience
The 4.5-star rating CCRH maintains across a substantial volume of reviews reflects several recurring themes in patient feedback. Patients consistently credit Dr. Mor with being thorough, knowledgeable, and willing to engage with complex or difficult cases. The clinic's multi-site model means that patients who live or work in the West Hollywood corridor or in the Santa Clarita Valley (near the Valencia location) can access monitoring and appointments closer to home, reducing travel burden during the intensive monitoring phase of an IVF cycle.
The clinic's international patient program — with Chinese-language resources and explicit accommodation for patients traveling from abroad — reflects a patient population that extends well beyond the local Valley community. This international orientation has helped build clinical volume and experience across a wide range of diagnoses and patient backgrounds.
Staff availability and communication responsiveness appear in reviews as key drivers of both satisfaction and occasional frustration, consistent with the patterns seen across high-volume fertility practices. Patients who enter treatment with clear questions and a realistic understanding of timelines tend to report the smoothest experience. The clinic offers a patient portal for communication and access to records, and provides detailed resources covering injection instructions, sperm bank referrals, and pharmacy coordination to support patients navigating the logistical complexity of fertility treatment.
For patients comparing Valley-area programs against the broader Southern California market, our guide to fertility clinics in California provides a statewide orientation to clinic options, SART reporting, and what to look for when evaluating a program.
Considering At-Home Insemination?
Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.
At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.
If you have a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.
Insurance and Financing
California's insurance landscape for fertility care shifted significantly at the start of 2026. Senate Bill 729 (SB 729), effective January 1, 2026, requires fully insured large-group health plans — those covering 101 or more employees and regulated under California's Department of Insurance or Department of Managed Health Care — to cover infertility diagnosis and treatment. The mandate includes up to three complete egg retrieval cycles per lifetime and unlimited embryo transfers, along with associated monitoring, lab work, and medications. Critically, SB 729 uses an inclusive definition of infertility that extends eligibility to LGBTQ+ individuals and single people who have not previously been diagnosed under traditional clinical definitions.
The practical effect is that many California employees working at large companies now have meaningful fertility coverage for the first time. However, SB 729 does not apply to self-funded employer health plans (which are governed by federal ERISA law and exempt from state benefit mandates), small-group plans, individual market plans, or Medi-Cal. Before scheduling a consultation, confirm with your HR department or benefits administrator whether your plan is fully insured and California-regulated.
For patients without applicable insurance coverage, CCRH offers financing options to help spread treatment costs. The clinic's website also provides a dedicated page on infertility insurance coverage to help patients understand their specific benefit situation. Patients should request an itemized cost estimate at their initial consultation — out-of-pocket costs vary considerably depending on the treatment protocol, medication response, number of cycles required, and whether donor material or genetic testing is involved.
For a full explanation of the IVF treatment process — from ovarian stimulation and egg retrieval through embryo transfer and the two-week wait — our IVF guide walks through each stage in clinical detail.
Frequently Asked Questions
What insurance does California Center for Reproductive Health accept? The clinic accepts a range of insurance plans and works with patients to verify benefits before treatment begins. With the implementation of SB 729 in 2026, many large California employers now provide fertility coverage. Contact the clinic's billing team with your insurance information to confirm in-network status and covered services before your first appointment.
Does CCRH have an egg donation program? Yes. The clinic operates both a recipient program (for patients using donor eggs) and a donor recruitment program. The egg donation section of the clinic's website includes information for both intended parents and prospective donors. The clinic also coordinates with external egg donation agencies for patients who prefer to work with a specific agency-managed donor pool.
What does the Access IVF program offer? Access IVF is the clinic's lower-cost IVF pathway, designed for patients who may not need or want full conventional ovarian stimulation. It typically involves minimal stimulation protocols that use lower medication doses and retrieve fewer eggs per cycle, reducing both the cost and the physiological burden compared to a standard IVF cycle. It is not appropriate for all patients — eligibility depends on ovarian reserve, age, diagnosis, and clinical history — but it provides a meaningful option for patients for whom cost is a significant barrier.
Can out-of-state or international patients use CCRH? Yes. The clinic has an established international patient program, including Chinese-language resources, hotel and logistics guidance, and protocols for coordinating with local monitoring physicians in other states or countries. Patients who cannot travel frequently during the monitoring phase of an IVF cycle should discuss remote monitoring arrangements during their initial consultation.